Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The pathogen Staphylococcus aureus uses various strategies for persisting in the host, among which switching to a small-colony variant (SCV) phenotype is of particular biological and therapeutic significance. Phenotypically, SCVs are characterized by a slow growth rate, atypical colony morphology and unusual biochemical features, constituting a real challenge for identification by the clinical microbiology laboratory. Their metabolic defects also alter their susceptibility to antibiotics, which, combined with the ability to survive intracellularly and, for some strains, to form biofilms, largely contributes to therapeutic failures. This paper reviews the available literature on antibiotic activity against SCVs of S. aureus in vitro, in animal models and in clinics. In vitro, aminoglycosides and antifolate agents show high MICs for electron-transport-defective and thymidine-dependent SCVs, respectively. The other antibiotic classes usually show MICs comparable to those measured for the parental strains, but they are less bactericidal. Intracellularly, auxotrophs for thymidine, haemin or menadione show contrasting behaviours with respect to their response to antibiotics, resulting from differences in their intracellular fate. In animal models, SCVs often persist in various locations, including metastatic ones, in spite of the administration of active antibiotics. In healthcare, several case reports mention the selection of SCVs after prolonged administration of not only aminoglycosides and antifolate agents, but also several other antibiotic classes. Apparent eradication requires several weeks or even months of aggressive polytherapy combined, whenever possible, with surgical intervention. Further research is thus warranted for optimizing the treatment of infections caused by SCVs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Self-citationTuchscherr, L., Medina, E., Hussain, M., Völker, W., Heitmann, V., Niemann, S., Holzinger, D., Roth, J., Proctor, R. A., Becker, K., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000115 · Cited by 437
Self-citationKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Self-citationvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Self-citationSingh, R., Ray, P., Das, A., & Sharma, M. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009720-0 · Cited by 262
von Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Self-citationStaphylococcus aureus Small Colony Variants in Prosthetic Joint Infection
Sendi, P., Rohrbach, M., Graber, P., Frei, R., Ochsner, P. E., & Zimmerli, W. (2006) · Clinical Infectious Diseases · doi:10.1086/507633 · Cited by 232
Gao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
Prunier, A., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J., & Leclercq, R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374937 · Cited by 199
Cited by
Items 101–177 of 177
Rong, Z., Chen, X., Qin, L., Wang, X., Luo, F., Zou, Q., & Zeng, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1592086 · Cited by 21
Miller, S. A., Karichu, J. K., Kohner, P. C., Cole, N. C., Hindler, J. A., Patel, R., Richter, S. S., & Humphries, R. M. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02211-16 · Cited by 17
Schleimer, N., Kaspar, U., Drescher, M., Seggewiß, J., von Eiff, C., Proctor, R. A., Peters, G., Kriegeskorte, A., & Becker, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01863 · Cited by 17
Self-citationWang, X., Li, W., Wang, W., Wang, S., Xu, T., Chen, J., & Zhang, W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.756809 · Cited by 17
The Clinical Significance of Staphylococcus aureus Small Colony Variants
Keim, K. C., George, I. K., Reynolds, L., & Smith, A. C. (2022) · Laboratory Medicine · doi:10.1093/labmed/lmac101 · Cited by 18
Jimi, S., Miyazaki, M., Takata, T., Ohjimi, H., Akita, S., & Hara, S. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000461 · Cited by 16
“Furthermore, it is also known that small colony variants appear as bacterial subpopulations with higher drug-resistance capacity after treatment with antibacterial drugs [9].”
Gounani, Z., Karaman, D. Ş., Venu, A. P., Cheng, F., & Rosenholm, J. M. (2020) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2020.105994 · Cited by 20
McLean, K., Holmes, E. A., Penewit, K. M., Lee, D. K., Hardy, S. R., Ren, M., Krist, M. P., Huang, K., Waalkes, A., & Salipante, S. J. (2019) · Infection and Immunity · doi:10.1128/iai.00884-18 · Cited by 17
Pathogenesis of Staphylococcus aureus
Becker, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809671-0.00002-4 · Cited by 32
Self-citationAl‐Maleki, A. R., Vellasamy, K. M., Mariappan, V., Gopinath, V., Tay, S. T., & Vadivelu, J. (2019) · Genomics · doi:10.1016/j.ygeno.2019.04.002 · Cited by 16
Carrilero, L., Urwin, L., Ward, E., Choudhury, N. R., Monk, I. R., Turner, C. E., Stinear, T. P., & Corrigan, R. M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00447-23 · Cited by 11
Du, C., Fikhman, D. A., Obeng, E. E., Can, S. N., Dong, K. S., Leavitt, E. T., Saldanha, L. V., Hall, M., Satalin, J. M., Kollisch-Singule, M. C., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.09.036 · Cited by 14
Dismantling the bacterial virulence program
Alford, M. A., Pletzer, D., & Hancock, R. E. W. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13388 · Cited by 13
Animal Models of Orthopedic Implant-Associated Infections and Revisions
Chen, F., Schiffer, N. E., & Song, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02331 · Cited by 15
Hosseinkhan, N., Mousavian, Z., & Masoudi‐Nejad, A. (2017) · Gene · doi:10.1016/j.gene.2017.10.005 · Cited by 13
No Change, No Life? What We Know about Phase Variation in Staphylococcus aureus
Gor, V., Ohniwa, R. L., & Morikawa, K. (2021) · Microorganisms · doi:10.3390/microorganisms9020244 · Cited by 18
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays
Subramaniam, S., Joyce, P. M., Ogunniyi, A. D., Dube, A., Sampson, S. L., Lehr, C., & Prestidge, C. A. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00613 · Cited by 10
Staphylococcus aureus Dormancy: Waiting for Insurgency
Nasser, A., Jahanbakhshi, S., Dallal, M. M. S., Banar, M., Sattari-Maraji, A., & Azimi, T. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230411110002 · Cited by 13
Functional mgrA Influences Genetic Changes within a Staphylococcus aureus Cell Population over Time
Lee, J. D., Carda‐Diéguez, M., Žiemytė, M., Vreugde, S., Cooksley, C. M., Crosby, H. A., Horswill, A. R., Mira, Á., Zilm, P. S., & Kidd, S. P. (2022) · Journal of Bacteriology · doi:10.1128/jb.00138-22 · Cited by 9
Scotti, L., Lima, E. D. O., da Silva, M. S., Ishiki, H. M., Lima, I. O., Pereira, F. D. O., Mendonça, F. J. B., & Scotti, L. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026613666131113151347 · Cited by 9
“com presenting cells and induce a strong IL-10 response that down regulates the adaptive T cell response [1,2].”
Greninger, A. L., Addetia, A., Tao, Y., Adler, A., & Qin, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-86764-4 · Cited by 8
Exploring Staphylococcus aureus Virulence Factors; Special Emphasis on Staphyloxanthin
Yehia, F. A.-Z. A., Yousef, N., & Askoura, M. (2021) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2107.07008 · Cited by 7
The crafty opponent: the defense systems of Staphylococcus aureus and response measures
Hou, H., Yang, L., Jin, Y., Chen, S., Long, J., Duan, G., & Yang, H. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00954-9 · Cited by 8
Al‐Bakri, A. G., Dahabiyeh, L. A., Khalil, E. A., Jaber, D., Kamel, G. S., Schleimer, N., Köhler, C., & Becker, K. (2022) · Antibiotics · doi:10.3390/antibiotics11111607 · Cited by 8
Self-citationAllan, D. S., & Holbein, B. E. (2022) · Antibiotics · doi:10.3390/antibiotics11111642 · Cited by 7
Savini, V., Carretto, E., Polilli, E., Marrollo, R., Santarone, S., Fazii, P., D’Antonio, D., Rossano, A., & Perreten, V. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02861-13 · Cited by 7
Antimicrobial Resistance in Staphylococci at the Human– Animal Interface
Schmidt, T., Kock, M. M., & Ehlers, M. M. (2015) · InTech eBooks · doi:10.5772/61785 · Cited by 13
Moldovan, A., Flannagan, R. S., Rühling, M., Stelzner, K., Hans, C., Paprotka, K., Kunz, T. C., Heinrichs, D. E., Rudel, T., & Fraunholz, M. J. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013291 · Cited by 6
“SCVs, an extensively studied form of S. aureus persisters [51,57,60,73–76], may arise in the absence of antibiotic selective pressure [77].”
Antimicrobial Resistance and Virulence Common Mechanisms
Giraud, É., Rychlík, I., & Cloeckaert, A. (2017) · Frontiers research topics · doi:10.3389/978-2-88945-181-4 · Cited by 6
Zhang, G., Zhao, Y., Hayes, A. J., Psaltis, A. J., Wormald, P., & Vreugde, S. (2018) · Allergy · doi:10.1111/all.13580 · Cited by 7
Small colony variants of Burkholderia pseudomallei : alteration of the virulence factors
Mariappan, V., Barathan, M., Zulpa, A. K., Vadivelu, J., & Vellasamy, K. M. (2023) · Journal of Taibah University for Science · doi:10.1080/16583655.2023.2244657 · Cited by 5
Host and microbial characteristics associated with recurrent prosthetic joint infections
Hampton, J. P., Zhou, J. Y., Kameni, F. Z. N., Espiritu, J. R., Manasherob, R., Cheung, E. V., Miller, M. D., Huddleston, J. I., Maloney, W. J., Goodman, S. B., et al. (2023) · Journal of Orthopaedic Research® · doi:10.1002/jor.25768 · Cited by 6
“21,23 Interestingly, S. aureus prevalence decreased from the initial to final spacer among recurrent ‐ PJI patients, while CoNS prevalence increased.”
BackgroundTada, T., Uechi, K., Nakasone, I., Miyazato, Z., Shinzato, T., Shimada, K., Tsuchiya, M., Kirikae, T., & Fujita, J. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000655 · Cited by 5
The in vitro evaluation of statins as antimicrobials for trauma-related chronic infectionPreprint
Trombetta, R. P., Lowak, K., Albach, A., Lopez, R., Romano, D. R., Sanchez, C., & Wenke, J. C. (2020) · doi:10.21203/rs.3.rs-15891/v1 · Cited by 4
Microgeography of staphyloccoci in human tissue explains antibiotic failurePreprint
Tripathi, V., Morin, B., Antelo-Varela, M., Loriol, A. A., Kurg, K., Jakonia, S., Ehsan, A., Herbert, S., Ferrand, A., Sauteur, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.12.675782 · Cited by 7
Antibiotic Resistance and Tolerance in Bacterial Biofilms
McKay, G. A., & Nguyen, D. M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_11 · Cited by 7
Respiration and Small Colony Variants of Staphylococcus aureus
Proctor, R. A. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch34 · Cited by 5
Self-citationHolbein, B. E., Ang, M. T. C., Allan, D. S., Chen, W., & Lehmann, C. (2021) · Sustainable agriculture reviews · doi:10.1007/978-3-030-58259-3_8 · Cited by 6
Bacterial Persistence in Biofilms and Antibiotics
Jolivet‐Gougeon, A., & Bonnaure‐Mallet, M. (2019) · Wiley eBooks · doi:10.1002/9781119282549.ch9 · Cited by 6
Advances in research on small colony variants of Staphylococcus aureus
Ye, Z., Chen, T., Zhang, Q., Huang, W., & He, L. (2025) · The Microbe · doi:10.1016/j.microb.2025.100444 · Cited by 4
Marín, V. N., Soliz, I. A. F., Valencia, J. W. A., Pletzer, D., Buccini, D. F., & Franco, O. L. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c01222 · Cited by 4
Aftab, I. B., Ahmed, A., Alvi, S., & Akhtar, F. (2021) · Electronic Journal of General Medicine · doi:10.29333/ejgm/11303 · Cited by 4
Liu, G. Y., & Bradley, J. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00024-x · Cited by 6
Gorr, S. (2025) · Journal of Bacteriology · doi:10.1128/jb.00505-24 · Cited by 2
“4A), which are associated with antibiotic resistance (31–34).”
Detection of Small Colony Variants Among Methicillin-Resistant Staphylococcus aureus Blood Isolates
Yağcı, S., Sancak, B., & Hasçelik, G. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0176 · Cited by 3
“28 However, recommendations for differential management of MRSA and MRSA SCVs are not yet been reported and clinical investigations are needed in this area.”
Role of biofilm in host–pathogen interaction
Sharma, S., Sharma, S., & Tiwari, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88480-8.00016-9 · Cited by 3
Antistaphylococcal activity of 2(5H)-furanone derivatives
Kayumov, A. R., Sharafutdinov, I., Trizna, E. Y., & Bogachev, M. I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-444-64279-0.00006-2 · Cited by 5
Simeonova Margarita, Y. (2017) · International Journal of Nanomaterials Nanotechnology and Nanomedicine · doi:10.17352/2455-3492.000019 · Cited by 3
“000019 obtained for antibacterial activity in vitro, the inclusion of CfH into PACA nanoparticles resulted in incomplete eradication of Salmonella persisting in organs of the mononuclear phagocyte system [18], most probably due to some non-dividing intracellular bacteria with less susceptibility to antibiotic treatmen…”
The Molecular Mechanics of Inflammatory Bone and Joint Disease Caused by Microbial Infection
Kavanagh, N., O’Brien, F. J., & Kerrigan, S. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811079-9.00008-2 · Cited by 3
Min, K., & Min, J. (2019) · Medicine · doi:10.1097/md.0000000000015499 · Cited by 5
Kwiecinski, J. M. (2014) · Phytotherapy Research · doi:10.1002/ptr.5159 · Cited by 3
Coenzyme A depletion causes antibiotic tolerance in Pseudomonas aeruginosaPreprint
Manfredi, P., Santi, I., Maffei, E., Gonzalez, H. A. H., Conroy, S., Lezan, E., Ahrné, E., Thürkauf, N., van Vliet, S., Zamboni, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684135 · Cited by 3
Liu, C., Chang, S., Shu, J., & Lin, M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01006-25 · Cited by 2
“Due to their slow metabolic rate and altered cell wall structure, SCVs typically exhibit reduced susceptibility to β-lac tams, aminoglycosides, and glycopeptides (28, 35).”
Small-colony variants of Staphylococcus aureus: hidden threat in chronic and recurrent infections
Khaja, A. S. S., Moursi, S. A., Saleem, M., Alshurtan, K. S., Abboh, E. A. A., Alshammari, A. D., Almalaq, H. A., Alshammari, M. N., & Almarshedy, S. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04917-y · Cited by 4
Controlled Release of Antimicrobial Small Molecules
Zilberman, M., Koren, E., Guez, H., & Matsliah, L. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012638-00068 · Cited by 3
Small colony variants and their clinical significance
Kandi, V. (2016) · Annals of Tropical Medicine and Public Health · doi:10.4103/1755-6783.177406 · Cited by 2
Radlinski, L. C., Rowe, S. E., Brzozowski, R., Wilkinson, A. D., Huang, R., Eswara, P. J., & Conlon, B. P. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3389379 · Cited by 2
Wang, L., Wang, T., & Zhao, Y. (2026) · Animals and zoonoses. · doi:10.1016/j.azn.2026.07.003 · Cited by 1
Staphylococcal Small Colony Variants from a Libyan Hospital
Ahmed, M. O., Aghila, E., Elramalli, A. K., & Agdih, M. S. (2015) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.154804 · Cited by 1
Cháves, F. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.10.015 · Cited by 1
The Clinical Significance ofStaphylococcus aureusSmall Colony Variants
Keim, K. C., George, I. K., Reynolds, L., & Smith, A. C. (2021) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.2020002691 · Cited by 1
“24,37,45”
InfluentialAntibiotic Resistance and Tolerance in Bacterial Biofilms
McKay, G. A., & Nguyen, D. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_11-1 · Cited by 1
Small Colony Variants – The Cause Of Chronic Infections
Nowicka, J., & Piątkowska, E. (2021) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2021.60.3.14
Pulmonary delivery for the treatment of tuberculosis
Poh, W. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/137335
(2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu932
Ortiz, S. L. D. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.9889
Colonization and Persistence Strategies of Staphylococcus aureus
Becker, K. (2024) · Springer eBooks · doi:10.1007/978-981-99-9428-1_1
Self-citationTieu, E., Griebel, B. T., Carroll, B., Eydinova, A., & Ma, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-65986-7_3
Cataño, J. C., Cardona‐Arias, J. A., & RESTREPO, M. S. (2024) · Acta Orthopaedica Belgica · doi:10.52628/90.4.12369
“…culture performance with a positivity of 62.5%, which constitutes a valuable finding to establish a precise etiology of these infections, since it avoids the excessive and irrational use of antibiotics empirically, thus also limiting the selection of different strains resistant to antibiotics 6,8 .”
InfluentialTerlizzi, V., Fevola, C., Dolce, D., Campana, S., Terri, A., Taccetti, G., & Chiappini, E. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05313-3
“Due to the unique metabolic characteristics of S. aureus SCVs, automated methods cannot reliably evaluate their chemosensitivity [24].”
Tracking eco-evolutionary dynamics among lung pathobiome members from children with cystic fibrosisPreprint
Schwyter, L., Kuratli, R., Provveduto, S., Silva, P. D. C., Latzin, P., Harrison, F., Hilty, M., & Kümmerli, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.29.702708
Staphylococcus aureus et infection du pied diabétique
Essebe, C. N. (2016) · theses.fr (ABES) · doi:10.70675/3d95eb62z1166z41c2z9668z735d5fc65c27
Valour, F. (2014) · theses.fr (ABES) · doi:10.70675/2582160fz517az4568z851dzfb94c3655fd5
“Les modifications des voies métaboliques impliquées dans le switch phénotypique sont à l’origine d’une résistance accrue aux antibiotiques [312,314].”
Thieme, L., Mirza, K. A., Azimi, M., Enslinger, N., Lohde, M., Jundzill, M., Brandt, C., Pletz, M. W., & Makarewicz, O. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05403-y
“Although SCVs and their subtypes have been extensively studied in S. aureus, their role in enterococcal infections remains poorly defined [2, 4, 25–28].”
Schwyter, L., Kuratli, R., Provveduto, S., Silva, P. D. C., Latzin, P., Harrison, F., Hilty, M., & Kümmerli, R. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01577-26
Metadata
- Authors
- Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F.
- Affiliations
- UCLouvain (BE)
- University Hospital Münster (DE)
- University of Wisconsin–Madison (US)
- Université Libre de Bruxelles (BE)
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-13
- Volume
- 68
- Issue
- 7
- Pages
- 1455-1464
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2096404632
- Cited by
- 177
- References
- 70
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 9 · 2023: 5 · 2022: 11 · 2021: 16 · 2020: 14 · 2019: 24 · 2018: 9 · 2017: 27 · 2016: 10 · 2015: 13 · 2014: 18 · 2013: 5
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Fonds De La Recherche Scientifique - FNRS (3.4530.12)
- Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Staphylococcus aureus, small colony variants, antibiotic susceptibility, aminoglycosides, antifolate, intracellular survival, biofilm, antibiotic resistance, persistent infection, polypharmacy, thymidine auxotrophy
- MeSH terms
- Animals, Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Phenotype, Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.